Glucocorticoid-Induced Adrenal Insufficiency
Endocrine Society, European Society of EndocrinologyPublished: May 28, 2024
- Key Points
- Management
- Figures and Algorithms:
- Schematic Representation of HPA Axis Recovery Following Discontinuation of Supraphysiologic Glucocorticoid Therapy
- Proposed Approach to Systemic Glucocorticoid Discontinuation
- Management of Patients at Risk of or With Diagnosed Glucocorticoid-Induced Adrenal Insufficiency With Suspected Adrenal Crisis or During Exposure to Stress
- Tables:
- Pharmacologic Characteristics of Commonly Prescribed Systemic Glucocorticoids
- Overview of Topics Prescribing Clinicians Should Discuss With Patients When Prescribing Oral Glucocorticoids
- Risk Factors for Developing Adrenal Insufficiency, and Susceptibility to Adrenal Crisis, During Glucocorticoid Therapy and Withdrawal from Therapy
- Suggested Tapering Regimen Depending on Glucocorticoid Dose
- Clinical Features of Adrenal Insufficiency, Glucocorticoid Withdrawal Syndrome and Common Underlying Conditions
- Non-oral Glucocorticoid Formulations and Risk of Glucocorticoid-induced Adrenal Insufficiency
- Signs and Symptoms of Glucocorticoid-induced (Exogenous) Cushing Syndrome
- Suggested Glucocorticoid Regimens in Patients at Risk of or With Diagnosed Glucocorticoid-Induced Adrenal Insufficiency During Exposure to Stress
- Signs and Symptoms of Adrenal Crisis and Potential Precipitating Factors
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.